Correlation between Soluble IL-2 Receptor Serum Levels and Regulatory T Lymphocytes in Patients with Solid Tumors

Wagner D.K. , Kiwanuka J. , Edwards B.K. . Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation to survival. J Clin Oncol 1987; 5: 1262–6.

Lissoni P. , Barni S. , Rescaldani R. , Rovelli F. , Tancini G. . Serum levels of soluble interleukin-2 receptors and their relation to lymphocyte subpopulations in patients with metastatic solid tumours. Br J Cancer 1989; 60: 616–7.

Rubin L.A. , Jay G. , Nelson D.L. . The released interleukin-2 receptor binds interleukin-2 efficiently. J Immunol 1986; 137: 3841–4.

Lissoni P. , Pittalis S. , Brivio F. . In vitro modulatory effects of interleukin 3 on macrophage activation induced by interleukin-2. Cancer 1993; 71: 2076–81.

Knutson K.L. , Disis M. , Salazar L. . CD4 regulatory T cells in human cancer pathogenesis. Cancer Immunol Immunother 2007; 556: 271–85.